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A B S T R A C T
Background: It remains unclear whether systemic arterial beds other than the coronary arteries are truly
healthy in patients without coronary artery lesions (CAL) after Kawasaki disease (KD). We tested the
hypothesis that patients with KD without echocardiographic evidence of CAL during the acute phase of
the disease have abnormal mechanical properties in systemic arteries later.
Methods and results: We studied 201 consecutive patients with KD (age 2–23 years, mean 10  4 years;
109 male, 92 female) without CAL during the acute phase. Data were compared with those in 129 control
subjects (age 2–25 years, mean 10  4 years; 73 male, 56 female; control group). We examined arterial
stiffness by using the brachial–ankle pulse wave velocity (baPWV) and the cardio-ankle vascular index
(CAVI). The baPWV in the KD group was signiﬁcantly higher than that in the control group (913  121 cm/s
vs. 886  135 cm/s, p = 0.04). In contrast, there was no signiﬁcant difference in CAVI (4.0  1.0 vs. 4.2  1.0,
p = 0.9) between the two groups. Multivariate analysis indicated a highly signiﬁcant difference in baPWV
(higher baPWV in patients with KD than in controls, p = 0.004), after controlling for age, gender, body height
and weight, and systolic and diastolic blood pressure, but no difference in CAVI between the groups.
Conclusion: Years after KD occurs in patients without apparent CAL during the acute phase, there is a
small but signiﬁcant change in systemic arterial properties, characterized by increased wall stiffness. The
clinical importance of these ﬁndings must be clariﬁed by performing long-term follow-up studies.
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Kawasaki disease (KD) [1,2] is the most commonly acquired
cardiovascular disease in developed countries and has serious
complications such as coronary vasculitis [3–5]. It has been
reported that KD causes structural and functional abnormalities
in systemic arterial beds, in addition to the coronary arteries, that
can last for years after the resolution of the acute illness [6–9]. This
is particularly true in patients who developed coronary artery
lesions (CAL) during the acute phase [3,10,11].
However, the majority of patients with KD do not exhibit CAL,
and information about the condition of systemic arterial beds in* Corresponding author at: Pediatric Cardiology, Saitama Medical Center, Saitama
Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
Tel.: +81 49 228 3717; fax: +81 49 228 3863.
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http://dx.doi.org/10.1016/j.jjcc.2014.10.003
0914-5087/ 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsthese patients is limited. Since the location and severity of KD-
induced vasculitis are not uniform [3,10], KD might affect systemic
arterial beds even in the absence of coronary artery abnormalities.
In the present study, we tested the hypothesis that patients with
KD but no echocardiographic evidence of CAL during the acute
phase have abnormal systemic artery mechanical properties later.
Therefore, we examined arterial stiffness in a large number of
patients with a history of KD without CAL by using the measures of
brachial–ankle pulse wave velocity (baPWV) [12] and the cardio-
ankle vascular index (CAVI) [13–15].
Methods
Patients
We studied 201 consecutive patients with KD (age 2–26 years,
mean 10  4 years; 109 male, 92 female) who had developed either
transient or no coronary artery dilation during the acute phase, based reserved.
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visited outpatient clinics at Saitama Medical University for periodic
check-ups. Data were compared with those in 129 patients
(age 2–25 years, mean 10  4 years; 73 male, 56 female) who were
considered to have normal systemic arteries (control group). The
control subjects consisted of children who were referred to our clinics
for suspected heart murmurs or abnormal electrocardiographic
ﬁndings (i.e. incomplete right bundle branch block, grade I atrioven-
tricular block), but turned out to be normal (n = 95). Patients with
paroxysmal atrial or ventricular contractions (n = 8) or congenital heart
disease with a trivial hemodynamic abnormality (i.e. a small
ventricular or atrial septal defect, n = 26) were also included in the
control group. The study was approved by the Institutional Review
Board on Clinical Investigation at Saitama Medical University (No. 11-
151, International Medical Center, Saitama Medical University).
Measurements
The baPWV was measured by using a volume-plethysmographic
apparatus (Form/ABI; Colin Co., Ltd., Komaki, Aichi, Japan) as
reported previously [16]. Brieﬂy, the patient was examined in the
supine position, sphygmomanometer cuffs were wrapped on both
brachia and ankles, electrocardiogram electrodes were placed on
both wrists, and a microphone was placed on the left edge of the
sternum. The cuffs inﬂated and deﬂated automatically, and pulse
wave contours in the four extremities were recorded simultaneous-
ly. The pulse transit time between the brachial and ankle regions was
computed from these pulse volume recordings. The baPWV was
determined from the pulse transit time and the distance between
both segments.
The CAVI was measured with a VaSera VS-1000H (Fukuda
Denshi Co., Ltd., Tokyo, Japan) by the methods described
previously [14]. Speciﬁcally, the CAVI is determined by using
the following procedure, based on the heart–ankle PWV (haPWV):
haPWV is equal to the vascular length (L) from the aortic valve to
the ankle divided by the propagation time (T) of the pulse wave.
This propagation time (T) is determined by adding tb (the time
difference between the 2nd heart sound and the initial pulse wave
rise of the brachial artery) and tba (the time difference between
the initial pulse wave rise of the brachial artery and that of the
ankle artery). Finally, the haPWV is determined by using the
following equation: haPWV = L/(tb + tba) = L/T. The CAVI is
calculated by simultaneously inserting the measured blood
pressure into the following equation:









where Ps, systolic blood pressure; Pd, diastolic blood pressure; DP,
Ps  Pd; haPWV, heart–ankle pulse wave velocity; r, blood
density; a and b, constants.
The CAVI is ﬁnally approximated to the heart-femoral PWV by
using the constants a and b so that it can be compared toTable 1
Patient characteristics.
Kawasaki disease
Mean  SD 
Age (years) 10  4.1 
Female (%) 40 
Height (cm) 134  21 
Body weight (kg) 34  14 
Body mass index (kg/m2) 17.6  2.6 
Systolic blood pressure (mmHg) 105  11 
Diastolic blood pressure (mmHg) 61  8 
Heart rate (bpm) 75  12 
Interval from the onset of Kawasaki disease (years) 7.0  3.9 conventional PWV. Thus, the CAVI reﬂects central arterial stiffness
better than baPWV.
Vessel length was automatically estimated from the patient’s
height using a built-in algorithm based on the linear relationship
between the two variables [14,16]. This algorithm is not
necessarily validated for small children, especially those whose
body length is <120 cm. Nonetheless, we applied the same
algorithm for all subjects including small children, based on our
preliminary study regarding the relationship between arterial
length and body height. Using data obtained during cardiac
catheterization, which provided a direct measurement of aortic
length from the aortic root to the iliac artery, we found a strong
linear correlation between arterial length and body length
(R = 0.95) over a wide range of body lengths including those of
small children (40–177 cm, n = 60).
Measurements were repeated until pressure wave signals of a
good quality acceptable for analysis were obtained. In other words,
if the pressure signals were of good quality, the measurements
were performed just one time in each patient, which was the case
in most of the present patients. Special care was taken for small
children by asking the patients’ parents to be in the examination
room together throughout the measurements to calm the children.
For the same purpose, we often let the children watch some
cartoon videos during the measurements.
Statistical analyses
All values were expressed as mean  SD. The signiﬁcance of
differences in the mean values between the groups was assessed by
using the unpaired t-test. The differences in baPWV and CAVI
between the groups were further tested after controlling for age, body
mass index (BMI), sex, heart rate, and systolic and diastolic blood
pressure by using a multivariate regression model. A probability
value of p < 0.05 was considered to indicate statistical signiﬁcance.
All statistical analyses were performed by using JMP version 7.0 (SAS
Institute, Inc., Cary, NC, USA).
Results
Patient characteristics for each group are listed in Table 1. The
interval between the onset of KD to the time of this study was
7.0  3.9 years, ranging from 6 months to 20 years. There were no
signiﬁcant differences in the data between the groups. As summa-
rized in Table 2, baPWV in the KD group was slightly but signiﬁcantly
higher than that in the control group. In contrast, there was no
signiﬁcant difference in CAVI between the groups. Each group
included 2 hypertensive and two obese children (0.99% vs. 1.6% for
hypertension, p = 0.65, and 2.0% vs. 3.1% for obesity, p = 0.49), and the
results were similar when these subjects were excluded from
the analysis. As baPWV and CAVI are both inﬂuenced by blood
pressure levels, and because arterial stiffness can be affected by
several factors, including age, sex, heart rate, and BMI, we additionally (N = 201) Control (N = 129) p-Value
Range Mean  SD Range
2.3–26 10  4.7 2.5–25 0.58
37 0.73
88–176 135  23 92–183 0.61
12–69 35  16 13–87 0.48
12–26 17.7  3.6 12–33 0.65
84–145 108  11 82–137 0.98
38–91 63  7.6 44–83 0.95
51–113 73  12 45–107 0.46
0.5–20
Table 2
Comparison of baPWV and CAVI.
Kawasaki disease
(N = 201)
Control (N = 129) p-Value
Mean  SD Range Mean  SD Range
baPWV 913  121 665–1268 886  135 530–1282 0.04
CAVI 4.0  1.0 2.2–8.8 4.2  1.0 1.7–7.4 0.90
baPWV, brachial–ankle pulse wave velocity; CAVI, cardio-ankle vascular index.
Table 3
Effect of factors on the brachial–ankle pulse wave velocity.
Independent predictors Coefﬁcient R2 p-Value
SBP (per mmHg) 6.70 0.228 <0.001
Age (per year) 4.00 0.325 0.035
Group (1 vs. 2)a 32.0 0.288 0.009
Heart rate (bpm) 0.299
BMI 0.603
Sex (male vs. female) 0.974
SBP, systolic blood pressure; BMI, body mass index.
a Group was assigned as a categorical variable, with 1 for Kawasaki disease
without coronary artery lesions and 2 for the control group.
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these factors in a multivariate analysis. The results indicated a highly
signiﬁcant difference in baPWV (higher baPWV in patients with KD
than in controls, p = 0.009; Table 3). There was no signiﬁcant
difference in CAVI between the groups even after controlling for
these factors.
Discussion
Because CAL in KD is an important complication that
signiﬁcantly inﬂuences the prognosis, the pathophysiology of
coronary arteries in this disease has been studied extensively
[17–20]. Furthermore, consistent with the fact that KD presents as
a systemic vasculitis that can involve any type of vessel, structural
and functional abnormalities in pulmonary arteries as well as
systemic arteries other than coronary arteries have also been
reported in both acute and chronic phases of KD [10]. However,
such studies have been carried out primarily in patients with
coronary artery involvement during the acute phase, and data
regarding the state of systemic arteries in the chronic stage of
disease in patients with KD without CAL are limited. In addition,
the results of these studies are conﬂicting, as summarized in
Table 4. Dhillon et al. [21] were the ﬁrst to present data suggesting
the possibility of long-lasting abnormalities in systemic arterial
function in patients with KD without a history of coronary
artery involvement. They studied endothelial-dependent and -
independent dilation in the brachial arteries of 20 patients afterTable 4
Summary of previous studies investigating properties of systemic arteries in Kawasaki
Authors Number of KD patients without CAL Number of contr
Dhillon et al. [21] 17 20 
McCrindle [22] 30 60 
Ikemoto et al. [23] 31 20 
Cheung et al. [24] 29 36 
KD, Kawasaki disease; CAL, coronary artery lesions; FMD, ﬂow-mediated dilation; GT
increased, and (!) no change.
a Average data including 3 patients with coronary artery involvement.
b Average data including 22 patients with coronary artery involvement.KD. Of these, three patients who had CAL during the acute illness
were included. The authors demonstrated that ﬂow-mediated
arterial dilation (FMD), which indicates endothelium-dependent
dilation, but not the response to glyceryl trinitrate (GTN), an
endothelium-independent dilator, was reduced in patients with
KD, even in those without detectable early coronary artery
involvement. These results, however, were not reproduced in a
subsequent study by McCrindle [22], who compared 52 patients
with KD with varying levels of coronary artery involvement to
60 healthy control subjects. Of these, 30 patients with KD had no
history of coronary artery involvement during the acute stage. The
author found no signiﬁcant differences in FMD or GTN response in
the brachial artery between KD and control subjects, independent
of a history of coronary artery involvement. Ikemoto et al. [23] also
reported that FMD of the brachial artery in 31 patients with KD
without CAL was comparable to that in 20 healthy controls. Other
studies have assessed arterial stiffness in patients with KD without
CAL, but the results were also inconsistent. Cheung et al. [24]
assessed the stiffness of brachioradial arteries of 29 patients with
KD without CAL by measuring the local PWV and demonstrated
that the PWV of these patients was comparable to that in
37 patients with KD and CAL and was signiﬁcantly higher than that
in 36 age-matched controls. On the other hand, these results were
not observed by Ikemoto et al., who reported no signiﬁcant
difference in the brachial artery stiffness index between patients
with KD and controls [23].
Therefore, results regarding the state of systemic arterial beds
after KD in patients without CAL are so far inconsistent. This might
be largely due to the small number of patients in each study. In
addition, abnormalities in the systemic vascular beds in patients
with KD, if present, may be too subtle to yield consistency among
studies with few subjects. In fact, there was signiﬁcant overlap in
the data even in the studies of Dhillon and Cheung that
demonstrated signiﬁcant differences in FMD and PWV between
patients with KD and controls [21,24]. The fact that our results
were obtained from a large number of study subjects and
demonstrated a small but signiﬁcant increase in baPWV in
patients with KD is consistent with the above-mentioned results.
Therefore, taken together, it appears safe to say that systemic
arteries are not necessarily normal in patients with KD, even in
those without detectable coronary artery involvement. Results of
pathological studies [8,9,25–28] demonstrating intimal thickening
with ﬁbrous scar formation and smooth muscle proliferation in
systemic arteries of children who have had KD even years after
resolution of acute illness ﬁt with our data of increased baPWV in
the later phase of KD.
Of note, in this study we observed a signiﬁcant difference in
baPWV between patients with KD and the control group but not in
CAVI. Both baPWV and CAVI are indices of arterial stiffness, but
CAVI reﬂects stiffness of the whole arterial system from the aortic
root to the lower extremities and baPWV reﬂects the arterial disease patients without coronary artery involvement.
ols Patients’ age (years) Follow-up period (years) Key ﬁndings
13.0a 11.3a FMD #
GTN !
15.5  2.3b 11.2  3.7b FMD !
GTN !
13.1  2.6 11.6  1.6 FMD !
Stiffness !
8.9  3.2 6.2  2.4 bPWV "
N, glyceryl trinitrate; bPWV, brachioradial pulse wave velocity. (#) Reduced, (")
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(Eq. (1)). Thus, a disparity in changes between baPWV and CAVI
suggests that peripheral arteries are the site of the primary lesions
that last years after the acute phase of KD, even in patients without
coronary artery involvement. This is consistent with the fact that
the vasculitis associated with KD is most evident in small- and
medium-sized arteries. The results also suggest that measuring
both baPWV and CAVI might be useful to determine the location of
arterial stiffness.
Clinical implications
There is ongoing controversy about whether and/or how
physicians should follow patients with KD without evidence of
CAL [29]. Establishing a follow-up protocol (including the
discontinuation of follow-up) is as important in these patients
as in patients with cardiac complications, because patients without
CAL constitute the majority of patients with a history of this
disease. Arterial stiffness directly inﬂuences left ventricular
afterload [30] and coronary perfusion [31], and it also appears
to be approximately parallel to the extent of atherosclerosis in
adults [32]. Arterial stiffening per se may be sufﬁcient to cause
endothelial dysfunction [32]. Additionally, in longitudinal studies
of several diseases and conditions, arterial stiffness was shown to
be an independent predictor of cardiovascular morbidity and
mortality [33]. Thus, the results of the present study support
the need for long-term follow-up of patients with KD, even those
without evidence of CAL. As part of the follow-up, noninvasive
assessments of arterial stiffness and endothelial function should
also be incorporated.
Limitations
Our control group included patients who might not have truly
normal arteries (particularly those with atrial and ventricular
septal defects). However, the PWV values in the present control
group were similar to those reported in a previous study by
Niboshi et al. [34]. In addition, even if the arteries were not
completely normal in the present controls, this strengthens
rather than weakens our key ﬁnding of increased PWV in patients
with KD. Although a previous study indicated excellent
reproducibility of PWV measurements even in small children
[35], we did not test data reproducibility in the present study.
Instead, we tried to secure the accuracy of data by repeating
measurements until we obtained good quality signals acceptable
for the analysis. This point needs to be acknowledged as a study
limitation. Vessel lengths used for the calculation of PWV and
CAVI were not directly measured but estimated from the
patient’s height based on the uniform relationship between
the vessel length and body height independent of the patient’s
age. This could be a source of errors in calculated PWV and CAVI.
However, age distribution was similar between the two groups;
thus, potential errors due to applying the same algorithm to all
study subjects should have been equally introduced for each
group. Also, as already mentioned, our control data were similar
to those of the previous study by Niboshi et al. [34]. Therefore, we
believe the validity of the present results. Lastly, the present
study was cross-sectional; thus, serial assessment of arterial
stiffness should be performed to further clarify the pathological
importance of increased arterial stiffness in patients with KD
without coronary artery involvement.
Conclusions
We observed a small but signiﬁcant change in systemic arteries,
characterized by increased wall stiffness, years after the acutephase of KD in patients without apparent CAL during the acute
phase of the disease. The clinical importance of these ﬁndings must
be clariﬁed by long-term follow-up studies.
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